Winners of Out-of-This-World Art and Poetry Contest Announced on the International Space Station
The ISS National Lab-sponsored contest received nearly triple the number of entries as last year, more than 2,700 entries from students in 35 countries
KENNEDY SPACE CENTER, Fla., Feb. 5, 2025 /PRNewswire/ -- Students from around the world saw their space-themed works of pen, paint, and poetry floating in the cupola of the International Space Station (ISS) as part of a contest to spark student interest in science, technology, engineering, and mathematics (STEM) careers through the arts.
John Shoffner, a lifelong space enthusiast, aviator, entrepreneur, and pilot on Axiom Space's 2nd commercial astronaut mission to the space station, developed this unique student contest through his Perseid Foundation. In collaboration with the foundation, Axiom Space and the Limitless Space Institute helped to bring this opportunity to students worldwide through the sponsorship of the ISS National Laboratory®.
In this second year of the contest, the Perseid Foundation received more than 2,700 entries of art and poetry from 35 countries depicting students' ideas about what it is like to live and work in space. From these entries, Shoffner and a panel of judges selected four works of art and four poems, and then worked with NASA to transmit the winning pieces to the space station so crew members could print them. Winning works of art and poetry were each photographed in the cupola.
Shoffner has always loved space, art, and the combination of the two, and when he was 10 years old, he painted a picture of NASA astronaut Ed White. When Shoffner flew on Axiom Mission-2 (Axiom-2) as its pilot, he used his experience on the space station to excite kids about STEM learning. While on the orbiting laboratory, he recorded a message announcing the winners of the Perseid Foundation's first space-themed art and poetry contest.
The foundation announced the second contest's winners by sharing their photos and poetry on its website. The works returned to Earth in December at the conclusion of SpaceX's 31st Commercial Resupply Services mission for NASA. The winners will receive their space-station printed work of art and a certificate stating it has flown in space. Every student who entered the contest also received a digital participation certificate and a note from Shoffner.
Educational outreach and workforce development are key focus areas for the ISS National Lab. The success of future commercial low Earth orbit destinations requires a strong space industry workforce, and the ISS National Lab supports a number of educational outreach programs at every age level to help prepare the next generation of researchers, engineers, and explorers. The International Space Art and Poetry Contest is one way partners leveraged the ISS National Lab to engage youth across the globe to pique their interest in space and space-focused careers.
"For the second year in a row, the International Space Art and Poetry Contest has reignited my love for space beyond my wildest imagination. Bright minds from 35 countries around the world showcased wide-eyed curiosity, bright color, and aspirational words," said Shoffner about this year's contest. "I'm assured the future of the space program is in great hands."
He concluded this year's contest with a note for its participants: "Thank you, once again, for showing me the sky is not the limit," he said.
To learn more about ISS National Lab educational partners and opportunities for students to leverage the orbiting outpost to ignite their curiosity, including an upcoming funding opportunity, please visit our website.
Download a high-resolution image for this release: Space Art & Poetry
About the International Space Station (ISS) National Laboratory:The International Space Station (ISS) is a one-of-a-kind laboratory that enables research and technology development not possible on Earth. As a public service enterprise, the ISS National Laboratory® allows researchers to leverage this multiuser facility to improve quality of life on Earth, mature space-based business models, advance science literacy in the future workforce, and expand a sustainable and scalable market in low Earth orbit. Through this orbiting national laboratory, research resources on the ISS are available to support non-NASA science, technology, and education initiatives from U.S. government agencies, academic institutions, and the private sector. The Center for the Advancement of Science in Space® (CASIS®) manages the ISS National Lab, under Cooperative Agreement with NASA, facilitating access to its permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space. To learn more about the ISS National Lab, visit our website.
As a 501(c)(3) nonprofit organization, CASIS® accepts corporate and individual donations to help advance science in space for the benefit of humanity. For more information, visit our donations page.
Media Contact:
Patrick O'Neill 904-806-0035PONeill@ISSNationalLab.org
International Space Station (ISS) National LaboratoryManaged by the Center for the Advancement of Science in Space® (CASIS®)
1005 Viera Blvd., Suite 101, Rockledge, FL 32955 • 321.253.5101 • www.ISSNationalLab.orgView original content to download multimedia:https://www.prnewswire.com/news-releases/winners-of-out-of-this-world-art-and-poetry-contest-announced-on-the-international-space-station-302368937.html
SOURCE International Space Station National Lab
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
2 hours ago
- CNN
New tech reveals never-before-seen details in solar corona
A breakthrough in adaptive optics technology captured the clearest images to date of the sun's corona. The incredible resolution of the new images could provide new insights on some of the mysteries surrounding our star.
Yahoo
2 hours ago
- Yahoo
NASA orbiter saw something astonishing peek through Martian clouds
NASA's longest-running Mars mission has sent back an unprecedented side view of a massive volcano rising above the Red Planet, just before dawn. On May 2, as sunlight crept over the Martian horizon, the Odyssey spacecraft captured Arsia Mons, a towering, long-extinct volcano, puncturing a glowing band of greenish haze in the planet's upper atmosphere. The 12-mile-high volcano — nearly twice the height of Mauna Loa in Hawaii — punctures a veil of fog, emerging like a monument to the planet's ancient past. The space snapshot is both visually arresting and scientifically enlightening. "We picked Arsia Mons hoping we would see the summit poke above the early morning clouds," said Jonathon Hill, who leads Odyssey's camera operations at Arizona State University, in a statement, "and it didn't disappoint." SEE ALSO: An enormous Martian cloud returns every spring. Scientists found out why. Arsia Mons sits at the southern end of a towering trio of volcanoes called the Tharsis Montes. Credit: NASA / JPL-Caltech To get this view, Odyssey had to do something it wasn't originally built for. The orbiter, which has been flying around Mars since 2001, usually points its camera straight down to map the planet's surface. But over the past two years, scientists have begun rotating the spacecraft 90 degrees to look toward the horizon. That adjustment allows NASA to study how dust and ice clouds change over the seasons. Though the image is still an aerial view, the vantage point is of the horizon, similar to how astronauts can see Earth's horizon 250 miles above the planet on the International Space Station. From that altitude, Earth doesn't fill their entire view — there's enough distance and perspective for them to see the planet's curved edge meeting the blackness of space. Odyssey flies above Mars at about the same altitude. Arsia Mons sits at the southern end of a towering trio of volcanoes called the Tharsis Montes. The Tharsis region is home to the largest volcanoes in the solar system. The lack of plate tectonics on the Red Planet allowed them to grow many times larger than those anywhere on Earth. Together, they dominate the Martian landscape and are sometimes covered in clouds, especially in the early hours. But not just any clouds — these are made of water ice, a different breed than the planet's more common carbon dioxide clouds. Arsia Mons is the cloudiest of the three. Scientists have recently studied a particular, localized cloud formation that occurs over the mountain, dubbed the Arsia Mons Elongated Cloud. The transient feature, streaking 1,100 miles over southern Mars, lasts only about three hours in the morning during spring before vanishing in the warm sunlight. It's formed by strong winds being forced up the mountainside. The cloudy canopy on display in Odyssey's new image, according to NASA, is called the aphelion cloud belt. This widespread seasonal system drapes across the planet's equator when Mars is farthest from the sun. This is Odyssey's fourth side image since 2023, and it is the first to show a volcano breaking through the clouds. "We're seeing some really significant seasonal differences in these horizon images," said Michael D. Smith, a NASA planetary scientist, in a statement. "It's giving us new clues to how Mars' atmosphere evolves over time."
Yahoo
2 hours ago
- Yahoo
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass., June 08, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; "Modalis"), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. "SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD," stated Eva Chin, Executive Director of SOLVE FSHD. "SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials." "We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103," said Haru Morita, CEO of Modalis. "This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD." About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit About Modalis Therapeutics Corporation Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit View source version on Contacts SOLVE FSHDAlexandra Grant, House of Wilsonalexandrag@ Modalis Therapeutics CorporationCorporate Planning Departmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data